Genome-wide measures of DNA methylation in peripheral blood and the risk of urothelial cell carcinoma: a prospective nested case-control study

Pierre-Antoine Dugue, Maree T. Brinkman, Roger L. Milne, Ee Ming Wong, Liesel M. FitzGerald, Julie K. Bassett, Jihoon E. Joo, Chol-Hee Jung, Enes Makalic, Daniel F. Schmidt, Daniel J. Park, Jessica Chung, Anthony D. Ta, Damien M. Bolton, Andrew Lonie, Anthony Longano, John L. Hopper, Gianluca Severi, Richard Saffery, Dallas R. EnglishMelissa C. Southey, Graham G. Giles

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)664-673
JournalBritish Journal of Cancer
Volume115
Issue number6
DOIs
Publication statusPublished - Sep 2016

Keywords

  • urothelial cell carcinoma
  • bladder cancer
  • DNA methylation
  • peripheral blood
  • biomarker
  • EWAS

Cite this

Dugue, P-A., Brinkman, M. T., Milne, R. L., Wong, E. M., FitzGerald, L. M., Bassett, J. K., Joo, J. E., Jung, C-H., Makalic, E., Schmidt, D. F., Park, D. J., Chung, J., Ta, A. D., Bolton, D. M., Lonie, A., Longano, A., Hopper, J. L., Severi, G., Saffery, R., ... Giles, G. G. (2016). Genome-wide measures of DNA methylation in peripheral blood and the risk of urothelial cell carcinoma: a prospective nested case-control study. British Journal of Cancer, 115(6), 664-673. https://doi.org/10.1038/bjc.2016.237